Stay updated on PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.

Latest updates to the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov record for a completed Phase 2b study of PF-06480605 in adults with moderate-to-severe ulcerative colitis is now available, with its study design, outcome measures, eligibility criteria, and participating locations. The record also includes posted results information, a study protocol, and a statistical analysis plan.SummaryDifference100%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide NIH notice appears above the study record, pointing visitors to transition updates and FAQs and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site's footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now renders a 403 Forbidden error page, replacing the expected study content with a minimal error screen indicating access to this record is blocked.SummaryDifference19%

Stay in the know with updates to PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06480605 Efficacy in Ulcerative Colitis Clinical Trial page.